Sanya J. Thomas

Sanya J. Thomas

Auto-generated profile, based on publicly available information

Sanya J. Thomas

Pediatric Transplant & Immunocompromised Host Infectious Diseases Program, Pediatric Infectious Diseases Columbia University Irving Medical Center and New York‐Presbyterian, Morgan Stanley Children's Hospital New York New York USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2020 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
STSanya J. Thomas
Sanya J. Thomas
RYRebecca T. Young
Rebecca T. Young
WSWilliam J. Steinbach
William J. Steinbach
DLDebra J. Lugo
Debra J. Lugo

23 November 2025 in Pediatric Transplantation
Verified
Journal Article
Closed access
STSanya J. Thomas
Sanya J. Thomas
DDDaniel E. Dulek
Daniel E. Dulek
HGHayley A. Gans
Hayley A. Gans
YMYamada Masaki
Yamada Masaki
MMMarian G. Michaels
Marian G. Michaels

12 February 2024 in Frontiers in Pediatrics
Verified
Journal Article
Open access
STSanya J. Thomas
Sanya J. Thomas
COChristopher P. Ouellette
Christopher P. Ouellette
Neurologic complications, both infectious and non-infectious, are frequent among hematopoietic cell transplant (HCT) and solid organ transplant (SOT) recipients. Up to 46% of HCT and 50% of SOT recipients experience a neurological complication, including cerebrovascular accidents, drug toxicities, as well as infections. Defects in innate, adaptive, and humoral immune function among transplant recipients predispose to opportunistic infections, including central nervous system (CNS) disease. CNS infections remain uncommon overall amongst HCT and SOT recipients, compromising approximately 1% of total cases among adult patients. Given the relatively lower number of pediatric transplant recipients, the incidence of CNS disease amongst in this population remains unknown. Although infections comprise a small percentage of the neurological complications that occur post-transplant, the associated morbidity and mortality in an immunosuppressed state makes it imperative to promptly evaluate and aggressively treat a pediatric transplant patient with suspicion for viral meningoencephalitis. This manuscript guides the reader through a broad infectious and non-infectious diagnostic differential in a transplant recipient presenting with altered mentation and fever and thereafter, elaborates on diagnostics and management of viral meningoencephalitis. Hypothetical SOT and HCT patient cases have also been constructed to illustrate the diagnostic and management process in select viral etiologies. Given the unique risk for various opportunistic viral infections resulting in CNS disease among transplant recipients, the manuscript will provide a contemporary review of the epidemiology, risk factors, diagnosis, and management of viral meningoencephalitis in these patients


7 August 2020 in Journal of the Pediatric Infectious Diseases Society
Verified
Journal Article
Open access
PDF file
STSanya J Thomas
Sanya J Thomas
JKJacob T Kilgore
Jacob T Kilgore
BBBradford A Becken
Bradford A Becken
CCColeen K Cunningham
Coleen K Cunningham
ATAmelia B Thompson
Amelia B Thompson
We present the first published case of raltegravir-associated drug-reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a child without characteristic human leukocyte antigen haplotypes HLA-B*57:01 or HLA-B*53:01. A 4-year-old African American female with perinatally acquired human immunodeficiency virus infection was hospitalized for DRESS after starting a raltegravir-based antiretroviral regimen.

4 October 2023 in Transplant Infectious Disease
Verified
Journal Article
Closed access
VPVarvara Probst
Varvara Probst
STSanya J. Thomas
Sanya J. Thomas
COChristopher Philip Ouellette
Christopher Philip Ouellette